ACUTE PROMYELOCYTIC LEUKEMIA WITH PML-RARA
Clinical trials for ACUTE PROMYELOCYTIC LEUKEMIA WITH PML-RARA explained in plain language.
Never miss a new study
Get alerted when new ACUTE PROMYELOCYTIC LEUKEMIA WITH PML-RARA trials appear
Sign up with your email to follow new studies for ACUTE PROMYELOCYTIC LEUKEMIA WITH PML-RARA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising new combo targets leukemia cells without harming healthy ones
Disease control Recruiting nowThis study tests whether combining two chemotherapy drugs (tretinoin and arsenic trioxide) with an immunotherapy drug (gemtuzumab ozogamicin) works better than the two drugs alone for people with a specific type of leukemia called acute promyelocytic leukemia. About 151 newly dia…
Matched conditions: ACUTE PROMYELOCYTIC LEUKEMIA WITH PML-RARA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 09:49 UTC
-
New pill could replace IV for rare leukemia treatment
Disease control Recruiting nowThis study tests a new oral capsule (QTX-2101) combined with another drug (ATRA) in 150 adults newly diagnosed with low-risk acute promyelocytic leukemia (APL). The goal is to see if the oral version works as well as the standard IV treatment to achieve remission. Participants wi…
Matched conditions: ACUTE PROMYELOCYTIC LEUKEMIA WITH PML-RARA
Phase: PHASE3 • Sponsor: Quetzal Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New imaging study aims to spot leukemia hiding outside the bone marrow
Knowledge-focused Recruiting nowThis study uses three types of advanced body scans (PET/MR, PET/CT, and whole body MRI) to find leukemia that has spread outside the bone marrow in people newly diagnosed with acute myeloid leukemia (AML). About 77 participants will receive these scans to see how well they detect…
Matched conditions: ACUTE PROMYELOCYTIC LEUKEMIA WITH PML-RARA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 09:50 UTC